Clinical Trials Browser

Breast Neoplasms

NCT04767594 2026-04-13

PERFORM

Active not recruiting

1,407 enrolled

Breast

Breast Neoplasms

NCT06663787 2026-04-13

HER2 CR

Active not recruiting

50 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT05377684 2026-04-01

ROSE

Active not recruiting

450 enrolled

Breast

Breast Neoplasms

NCT03270072 2026-03-31

The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients

Active not recruiting

100 enrolled

Breast

Breast Neoplasms

NCT04918082 2026-03-31

Qualibreast-MQ

Active not recruiting

133 enrolled

Breast

Breast Neoplasms

NCT07493291 2026-03-30

PALLAS-IRAQ

Active not recruiting

100 enrolled

Breast

Breast Neoplasms

NCT04158258 2026-03-24

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active not recruiting

2,907 enrolled

Breast

Breast Neoplasms

NCT01030250 2026-03-23

Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life

Active not recruiting

238 enrolled

Breast

Breast Neoplasms

NCT02281149 2026-03-17

TOMOBREAST

Active not recruiting

500 enrolled

Breast

Breast Neoplasms

NCT05662345 2026-03-17

ACT-MBC

Active not recruiting

65 enrolled

Breast

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

Active not recruiting

1,019 enrolled

Breast

Breast Neoplasms

NCT05316389 2026-03-11

QUARLAMI

Active not recruiting

190 enrolled

Breast

Breast Neoplasms

NCT05926024 2026-03-11

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Active not recruiting

253 enrolled

Breast

Pathologic Complete Response, Breast Neoplasms

NCT06584396 2026-03-11

Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

Active not recruiting

140 enrolled

Breast

Breast Neoplasms

NCT02567669 2026-03-10

MUSFAT

Active not recruiting

20 enrolled

Breast

Breast Neoplasms, Fatigue, Sarcopenia

NCT03619083 2026-03-10

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Active not recruiting

187 enrolled

Breast

Breast Neoplasms

NCT04474834 2026-03-05

GENRE2

Active not recruiting

737 enrolled

Breast

Breast Neoplasms

NCT03846167 2026-03-03

FTT 2

Active not recruiting

50 enrolled

Breast

Breast Neoplasms

NCT07442838 2026-03-03

RA-IBBR-NvsM

Active not recruiting

88 enrolled

Breast

Breast Neoplasms, Postoperative Complications

NCT05046301 2026-02-25

Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications

Active not recruiting

59 enrolled

Breast

Breast Neoplasms

NCT05942092 2026-02-23

SEED01

Active not recruiting

1,400 enrolled

Breast

Breast Neoplasms

NCT01517945 2026-02-20

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Active not recruiting

252 enrolled

Breast

Breast Neoplasms

NCT05488483 2026-02-19

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

Active not recruiting

12 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT05703399 2026-02-19

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

Active not recruiting

140 enrolled

Breast

Breast Neoplasms

NCT06756802 2026-02-17

ISIS

Active not recruiting

22,000 enrolled

Breast

Breast Neoplasms

NCT05939128 2026-02-12

ERA

Active not recruiting

625 enrolled

Breast

Breast Neoplasms

NCT07342309 2026-02-10

Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

Active not recruiting

7,933 enrolled

Breast

Breast Neoplasms

NCT03749421 2026-02-06

Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer

Active not recruiting

60 enrolled

Breast

Breast Neoplasms

NCT03424915 2026-02-04

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active not recruiting

42 enrolled

Breast

Breast Neoplasms

NCT01468246 2026-02-03

HOHO

Active not recruiting

1,302 enrolled

Breast

Breast Neoplasms

NCT05054010 2026-02-02

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

Active not recruiting

84 enrolled

Breast

Breast Neoplasms

NCT03615599 2026-01-30

AHS-2

Active not recruiting

96,000 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04595435 2026-01-29

IORT-Breast

Active not recruiting

94 enrolled

Breast

Breast Neoplasms

NCT01992432 2026-01-28

Brain fMRI-BC

Active not recruiting

49 enrolled

Breast

Breast Neoplasms

NCT06533670 2026-01-28

TME Alteration in HER2 Positive Breast Cancer

Active not recruiting

30 enrolled

Breast

Breast Neoplasms

NCT07148141 2026-01-28

FERTICAN

Active not recruiting

100 enrolled

Breast

Breast Neoplasms, Infertility, Female

NCT06833723 2026-01-15

Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

Active not recruiting

1,000 enrolled

Breast

Breast Neoplasms

NCT04854005 2026-01-12

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Active not recruiting

78 enrolled

Breast

Breast Neoplasms

NCT06234488 2026-01-12

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Active not recruiting

125 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT01505400 2026-01-08

IMPACT

Active not recruiting

3,026 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Unknown Primary, Urogenital Neoplasms, Colorectal Neoplasms

NCT04308720 2026-01-08

Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer

Active not recruiting

217 enrolled

Breast

Breast Neoplasms

NCT00579163 2026-01-07

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Active not recruiting

992 enrolled

BreastGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasm

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Non-Hodgkin, Ovarian Neoplasms, Prostatic Neoplasms

NCT00582478 2026-01-07

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

Active not recruiting

650 enrolled

Breast

Breast Neoplasms

NCT00588029 2026-01-07

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

Active not recruiting

7,000 enrolled

Breast

Breast Neoplasms

NCT00589654 2026-01-07

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Active not recruiting

810 enrolled

Breast

Amenorrhea, Breast Neoplasms

NCT07316439 2026-01-05

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Active not recruiting

197 enrolled

Breast

Breast Neoplasms

NCT06083038 2025-12-31

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Active not recruiting

15 enrolled

Breast

Breast Neoplasms, Hyperglycemia

NCT04989179 2025-12-26

PMPS

Active not recruiting

220 enrolled

Breast

Breast Neoplasms

NCT03892655 2025-12-24

LB1802

Active not recruiting

170 enrolled

Breast

Breast Neoplasms

Clinical Trials

RESCUE

PERFORM

HER2 CR

ROSE

The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients

Qualibreast-MQ

PALLAS-IRAQ

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life

TOMOBREAST

ACT-MBC

RosaLEE

QUARLAMI

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

MUSFAT

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

GENRE2

FTT 2

RA-IBBR-NvsM

Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications

SEED01

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

ISIS

ERA

Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

HOHO

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

AHS-2

IORT-Breast

Brain fMRI-BC

TME Alteration in HER2 Positive Breast Cancer

FERTICAN

Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

IMPACT

Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

PMPS

LB1802